cryptococcoma

Cryptococcoma refers to a localized, granulomatous mass caused by Cryptococcus neoformans infection. These lesions are typically found in the central nervous system, particularly the brain, but can also occur in the lungs or other organs. The formation of a cryptococcoma is a host response to the fungus, aiming to contain the infection. Macroscopically, cryptococcomas appear as discrete, often encapsulated masses that can vary in size. Histologically, they are characterized by the presence of yeast cells of Cryptococcus neoformans, surrounded by inflammatory cells such as neutrophils, lymphocytes, and macrophages. Giant cells may also be present. The capsule of the yeast, primarily composed of glucuronoxylomannan, is a key component that contributes to the pathogenicity of Cryptococcus and can elicit a granulomatous reaction. Clinical presentation depends on the location of the cryptococcoma. In the brain, symptoms can include headache, seizures, focal neurological deficits, and signs of increased intracranial pressure. Pulmonary cryptococcomas may be asymptomatic or present with cough, chest pain, and dyspnea. Diagnosis is often made through imaging studies such as MRI or CT scans, followed by cerebrospinal fluid analysis or biopsy for definitive identification of the fungus. Treatment involves antifungal medications, with the duration and choice of agents depending on the extent and location of the infection, as well as the patient's immune status. Surgical intervention may be considered for large or symptomatic lesions, particularly in immunocompromised individuals.